In esophageal squamous cell carcinoma, an increased ATP6V1C1 to ATP6V1C2 ratio, reflecting the upregulation of ATP6V1C1 and downregulation of ATP6V1C2, has been identified as a distinctive molecular characteristic of the disease (41). This evidence concerns the gene ATP6V1C1 and esophageal squamous cell carcinoma.